medicaid glp-1 State Programs Increasingly Opting To Cover Weight-Loss Drugs US states drop Medicaid coverage

This study also highlights that the total body weight loss percentages recorded were 5.9% at three months and 10.9% at six months

The New York-based company does not take insurance to keep prices down for those who need to pay cash due to a lack of insurance or high deductibles

June 2024: Mounjaro manufacturer issued an Open Letter warning patients against using the drug for cosmetic weight loss and counterfeit versions of the drug

YOU COULD SEE REAL RESULTS IN LESS THAN 3 MONTHS ABOUT 54% of our GLP-1 Patients See a Significant Change in the way their clothes fit in less than 3 months

Some individuals utilize smart water bottles to help remind them throughout the day. What UAB clinicians are observing At UAB, clinicians are seeing more individuals incorporate GLP1 medications into their diabetes and cardiometabolic care, yet that trend has not translated into higher rates of kidney stones